HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine

作者：Kristen Marks, Minhee Kang, Triin Umbleja, Andrea L. Cox, Karen J. Vigil, Anchalee Avihingsanon, Patcharaphan Sugandhavesa, Leolin Katsidzira, Josphat Kosgei, Hugo Perazzo, Jennifer C. Price, Stephanie Caruso, Kevin Knowles, Beverly Alston‐Smith, Parita Rathod, Kenneth E. Sherman, ACTG 5379 (BEe-HIVe) Study Team, Oladapo Alli, Ceora Beijer, Stephanie Caruso, Shawn Chiambah, Lillian Collins, Kim Epperson, Françoise Giguel, Jan Kosmyna, Michael Leonard, Terence Mohammed, Leonard Sowah, Christina Vernon, Sara Zabih, Katrina Shea, M. Gustave Planchon, Paul E. Sax, Cheryl Keenan, Joyce Jones, Alex Hessel, Aleen Khodabakhshian, L. Lawrence Mark, Eric S. Daar, Ruben Lopez, Rosemarie Ramirez, Dawn Rosenblum, Dennis Dentoni-Lasofsky, Cecilia Rivas Alfaro, Madhu Choudhary, Jen Sullivano, Rachel Bender Ignacio, Eli Burnham, Teresa Spitz, Raghd Alyatim, Susan L. Koletar, Robyn Cicarella, Carl J. Fichtenbaum, Michelle Saemann, Leila S Hojat, Brenda Brown, Vivek Daniel Paul, Claudia Hawkins, Jaclyn Leone, Jonathan Oakes, Cornelius Van Dam, Kelly Phillips, Tracey Watkins, Ericka Patrick, Clifford Gunthel, Joslyn Axinn, Nicola Haakonsen, William R. Short, Pablo Tebas, Keisha Ballentine-Cargill, Nadi Islam, Daniel K. Finn, Catherine Jerry, Sharlaa Badal‐Faesen, Iveshni Govender, Penelope Madlala, Rosie Mngqibisa, Nathália Soliva, Tania Brum, Breno Santos, Rita de Cássia Alves Lira, Lerato Mohapi, Nadia Marengo, Sandra Rwambuya, Francis Ssali, Josphat Kosgei, Geoffrey Koskei, Ditlamelo Mareme, Boitshepho Seme, Mulinda Nyirenda, Maxwell Yohane, Michael T. Yin, Anyelina Cantos, Karen J. Vigil, Mariano J. Lodigiani, Patcharaphan Sugandhavesa, Daralak Tavornprasit, Shobha Swaminathan, Christie Lyn Costanza, Sonal S. Munsiff, Susan E. Hulse, Sonya L. Heath, Edgar T. Overton, Megan Dieterich, Carrington Koebele, Anchalee Avihingsanon, Hay Mar Su Lwin, Maria Tarcela Gler, Melchor Frias, Ngan Ta Thi Dieu, Dat Quoc Vu · 发表于：JAMA · 年份：2025 · DOI：10.1001/jama.2025.9894 · 被引用次数：4 · 研究领域：Hepatitis B Virus Studies、Hepatitis C virus research、Vaccine Coverage and Hesitancy

This study provides the end-of-study results on the durability of seroprotection response in a trial comparing 2- and 3-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG) vs 3-dose hepatitis B vaccine with an aluminum hydroxide adjuvant.